BioHarvest Sciences Inc. Common Stock (BHST) Stock Price

BHSTStock

$1.85−46.88%52W

Market Cap$41.94M

P/E—

PEG Ratio—

Div yield—

Beta-0.34

BHST Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-21.65%

Price vs S&P 500 (4W)-0.97%

VGM Score62.80

Book Value / Share (Quarterly)$0.24

Revenue Growth (3Y)217.48%

Cash Flow / Share (Quarterly)$-0.58

Price vs S&P 500 (YTD)-43.47%

Gross Margin (TTM)54.00%

Net Profit Margin (TTM)-76.65%

EPS (TTM)$-1.19

10-Day Avg Trading Volume0.07M

EPS Excl Extra (TTM)$-1.19

EPS (Annual)$-0.93

ROI (Annual)-178.22%

Gross Margin (Annual)44.45%

Cash / Share (Quarterly)$0.16

Revenue Growth QoQ (YoY)101.88%

ROA (Last FY)-96.27%

Revenue Growth TTM (YoY)111.68%

EBITD / Share (TTM)$-0.44

Operating Margin (TTM)-35.00%

Cash Flow / Share (Annual)$-0.02

P/B Ratio12.07x

P/B Ratio (Quarterly)32.45x

Net Income / Employee (Annual)$-141,200

EV / Revenue (TTM)2.58x

Net Interest Coverage (TTM)-11.14x

ROA (TTM)-85.16%

EPS Incl Extra (Annual)$-0.93

Current Ratio (Annual)1.94x

Quick Ratio (Quarterly)0.48x

3-Month Avg Trading Volume1.16M

52-Week Price Return-46.88%

Revenue / Employee (TTM)$252,000

Tangible BV / Share (Quarterly)$-0.02

P/S Ratio (Annual)3.94x

Asset Turnover (Annual)0.21x

52-Week High$0.38

EPS Excl Extra (Annual)$-0.93

26-Week Price Return-20.93%

Quick Ratio (Annual)1.62x

13-Week Price Return-45.93%

Total Debt / Equity (Annual)0.93x

Current Ratio (Quarterly)0.80x

Enterprise Value$57.89M

Asset Turnover (TTM)1.11x

Revenue / Employee (Annual)$142,400

Inventory Turnover (Annual)3.71x

Pretax Margin (Annual)-99.15%

Cash / Share (Annual)$0.01

3-Month Return Std Dev60.76%

Net Income / Employee (TTM)$-193,200

ROE (Last FY)-344.20%

Net Interest Coverage (Annual)-0.58x

EPS Basic Excl Extra (Annual)$-0.93

Receivables Turnover (TTM)14.40x

Total Debt / Equity (Quarterly)2.58x

EPS Incl Extra (TTM)$-1.19

Receivables Turnover (Annual)4.32x

ROI (TTM)-21.15%

P/S Ratio (TTM)2.23x

Revenue / Share (Annual)$0.94

Tangible BV / Share (Annual)$-0.02

Price vs S&P 500 (52W)-46.24%

Year-to-Date Return-41.38%

5-Day Price Return2.96%

EPS Normalized (Annual)$-0.93

Net Profit Margin (Annual)-99.15%

Month-to-Date Return3.03%

Cash Flow / Share (TTM)$-0.03

EBITD / Share (Annual)$-0.71

Operating Margin (Annual)-78.65%

EPS Basic Excl Extra (TTM)$-1.19

P/B Ratio (Annual)73.09x

Inventory Turnover (TTM)3.92x

Pretax Margin (TTM)-76.65%

Book Value / Share (Annual)$0.01

Price vs S&P 500 (13W)-1.33%

Beta-0.34x

Revenue / Share (TTM)$1.29

ROE (TTM)-62.28%

52-Week Low$0.14

vGradeC

gGradeA

mGradeC

vgmGradeB

BHST Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.12	-$0.17	-44.68%(-$0.05)
Q1 2026	May 14, 2026	-$0.12	-$0.11	+8.33%(+$0.01)
Q4 2025	Mar 31, 2026	-$0.10	-$0.10	+4.76%(+$0.01)
Q3 2025	Nov 13, 2025	-$0.12	-$0.14	-21.74%(-$0.03)
Q2 2025	Aug 11, 2025	-$0.11	-$0.24	-123.26%(-$0.13)

BHST Analyst Recommendations

Jan 2025

Feb 2025

Mar 2025

Apr 2025

4.14

4.13

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
BHSTBioHarvest Sciences Inc. Common Stock	C	A	C	2.2x	111.7%	54.0%	—	$1.85
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences owns patented technology for large-scale plant cell cultivation that produces active plant ingredients directly, without growing whole plants. The company operates across two segments: nutraceuticals such as dietary supplements and botanical-derived Active Pharmaceutical Ingredients for therapeutic use. This platform approach offers potential advantages in production scalability and supply chain efficiency.